RxDoctor Payments Data

Robert Mullan, DPM

Podiatrist · Las Cruces, NMNPI 1033105812

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (50.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Organogenesis Inc. at 52.2% of the total. Among podiatrist clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,430in general payments, 2019–2025

Across 158 payments — averaging $198.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$16K
  • Flower Orthopedics Coporation$7K
  • Arthrosurface Incorporated$2K
  • Zimmer Biomet$836
  • 4web, Inc.$782
  • DJO, LLC$631
  • plus $3K from 24 others

What the payments were for

  • Consulting fees$7,20123%
  • Speaking & faculty fees$1,3494%
  • Travel & lodging$2,1687%
  • Food & beverage$4,71315%
  • Other$16,00051%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,430 in reported general payments places this provider in the 95th percentile of 46 podiatrist providers in New Mexico.

See all podiatrist providers in New Mexico

Medicare billing

Part B allowed, 2024
$152,948
Medicare patients
452
Services billed
1,647

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox40$2,008
Ketoconazole60$1,654
CiclopiroxCiclopirox Olamine69$1,388
Terbinafine Hcl75$1,133
Mupirocin26$365
Gabapentin25$308
Allopurinol25$269
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$230
Econazole Nitrate11$217
Ciprofloxacin Hcl20$195
Cephalexin20$194
Ibuprofen20$179
Triamcinolone Acetonide27$167
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$88
Pregabalin11$84

Paid to pharmacies, not to this prescriber.

Other podiatrist in Las Cruces

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →